| scholarly article | Q13442814 |
| P2093 | author name string | Dominique Meynial-Denis | |
| P2860 | cites work | mTOR signaling in growth control and disease | Q24634174 |
| Influence of amino acids, dietary protein, and physical activity on muscle mass development in humans | Q27003307 | ||
| Cellular and molecular mechanisms of muscle atrophy | Q27012762 | ||
| L-glutamine supplementations enhance liver glutamine-glutathione axis and heat shock factor-1 expression in endurance-exercise trained rats | Q28565930 | ||
| Glutamate and CO2 production from glutamine in incubated enterocytes of adult and very old rats. | Q30557899 | ||
| Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data | Q30656188 | ||
| Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells | Q33181375 | ||
| Intestinal and hepatic metabolism of glutamine and citrulline in humans | Q33277507 | ||
| Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. | Q33745051 | ||
| Changes in protein, carbohydrate, and fat metabolism with aging: possible role of insulin | Q33851787 | ||
| Regulative potential of glutamine--relation to glutathione metabolism. | Q33957782 | ||
| Almost all about citrulline in mammals | Q33989190 | ||
| Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? | Q33996663 | ||
| Skeletal muscle loss: cachexia, sarcopenia, and inactivity | Q34099406 | ||
| The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy | Q34106342 | ||
| Effect of a specialized amino acid mixture on human collagen deposition | Q34145689 | ||
| Recent molecular advances in mammalian glutamine transport | Q34353945 | ||
| Glutamine and cell signaling in liver | Q34353971 | ||
| Glutamine alimentation in catabolic state | Q34354033 | ||
| Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). | Q34378412 | ||
| Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group | Q34401526 | ||
| Protein and healthy aging. | Q34474359 | ||
| Control of protein synthesis by amino acid availability | Q34493700 | ||
| Glutamine: clinical applications and mechanisms of action. | Q34493707 | ||
| Calorie restriction enhances the expression of key metabolic enzymes associated with protein renewal during aging | Q34497503 | ||
| Metabolic bases of amino acid requirements in acute diseases | Q34530960 | ||
| Hepatic glutamine metabolism | Q34588796 | ||
| Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? | Q35038201 | ||
| Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function | Q35081514 | ||
| Glutaminolysis feeds mTORC1. | Q42414235 | ||
| Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. | Q42657469 | ||
| Consequences of age-related splanchnic sequestration of leucine on interorgan glutamine metabolism in old rats | Q43808695 | ||
| Do sex steroids regulate glutamine synthesis with age? | Q43819547 | ||
| Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes | Q44086589 | ||
| The use of calorie restriction mimetics to study aging | Q44447314 | ||
| The role of adrenal hormones in the response of glutamine synthetase to fasting in adult and old rats | Q44652994 | ||
| Metabolic acidosis stimulates intestinal glutamine absorption | Q44693496 | ||
| Identification of a molecular signature of sarcopenia | Q45248713 | ||
| Does acute glutamine depletion enhance the response of glutamine synthesis to fasting in muscle in adult and old rats? | Q46492673 | ||
| The 2007 ESPEN Sir David Cuthbertson Lecture: amino acids between and within organs. The glutamate-glutamine-citrulline-arginine pathway | Q46576667 | ||
| Premature senescence of human endothelial cells induced by inhibition of glutaminase. | Q46720253 | ||
| Programmed cell death and apoptosis in aging and life span regulation | Q46847525 | ||
| Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease | Q46884840 | ||
| Does long-term intermittent treatment with glutamine improve the well-being of fed and fasted very old rats? | Q46942197 | ||
| The TCA cycle as an oxidative and synthetic pathway is suppressed with aging in jejunal epithelial cells. | Q46989157 | ||
| Measuring dietary fatty acid intake:validation of a food-frequency questionnaire against 7 d weighed records | Q47780551 | ||
| Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice | Q47850208 | ||
| EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly. | Q47870294 | ||
| Adaptation of body protein metabolism in adult and aging man. | Q47905454 | ||
| Phenylbutyrate-induced glutamine depletion in humans: effect on leucine metabolism | Q48014644 | ||
| Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. | Q50981777 | ||
| Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model. | Q51101932 | ||
| Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. | Q51481624 | ||
| Does glutamine supplementation decrease the response of muscle glutamine synthesis to fasting in muscle in adult and very old rats? | Q51481928 | ||
| Opposite fluxes of glutamine and alanine in the splanchnic area are an efficient mechanism for nitrogen sparing in rats. | Q51568142 | ||
| Alpha-ketoglutarate inhibits glutamine degradation and enhances protein synthesis in intestinal porcine epithelial cells. | Q51588722 | ||
| Alterations in glutamine synthetase activity in rat skeletal muscle are associated with advanced age. | Q51797368 | ||
| The spatio-temporal control of the expression of glutamine synthetase in the liver is mediated by its 5'-enhancer. | Q52204701 | ||
| Glutaminolysis activates Rag-mTORC1 signaling. | Q52301079 | ||
| Perspective: Dietary protein needs of elderly people: protein supplementation as an effective strategy to counteract sarcopenia. | Q53853234 | ||
| L-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK. | Q54317810 | ||
| Enteral delivery of proteins stimulates protein synthesis in human duodenal mucosa in the fed state through a mammalian target of rapamycin-independent pathway. | Q54459907 | ||
| Effects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathways | Q54630109 | ||
| Co-ingestion of leucine with protein does not further augment post-exercise muscle protein synthesis rates in elderly men | Q57580388 | ||
| Safety of glutamine-enriched parenteral nutrient solutions in humans | Q68365651 | ||
| Glutamine synthetase induction by glucocorticoids is preserved in skeletal muscle of aged rats | Q71978088 | ||
| Age-related changes in protein synthesis measured in vivo in rat liver and gastrocnemius muscle | Q72091098 | ||
| Aging of the liver: proteolysis of oxidatively modified glutamine synthetase | Q72200066 | ||
| Enteral glutamine spares endogenous glutamine in chronic acidosis | Q72688787 | ||
| Hormonal and dietary control of hepatic glutamine catabolism | Q72794538 | ||
| Acute phase protein levels and thymus, spleen and plasma protein synthesis rates differ in adult and old rats | Q78753441 | ||
| Association between glutamine extraction and release of citrulline and glycine by the human small intestine | Q79960134 | ||
| [Circulating citrulline levels: a biomarker for intestinal functionality assessment] | Q82077505 | ||
| Age related profiles of free amino acids in human skeletal muscle | Q83223268 | ||
| Autophagy: a potential link between obesity and insulin resistance | Q84344548 | ||
| Regulative capacity of glutamine | Q35104873 | ||
| Challenges and new opportunities for clinical nutrition interventions in the aged | Q35110793 | ||
| Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases | Q35137642 | ||
| Amino acids as regulators of proteolysis | Q35138273 | ||
| Aging impairs contraction-induced human skeletal muscle mTORC1 signaling and protein synthesis. | Q35166239 | ||
| mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity | Q35209468 | ||
| Glutamine: metabolism and application in nutrition support. | Q35683679 | ||
| Exercise, amino acids, and aging in the control of human muscle protein synthesis. | Q35787793 | ||
| Aging Is Accompanied by a Blunted Muscle Protein Synthetic Response to Protein Ingestion | Q35831958 | ||
| Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers | Q35853129 | ||
| The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases | Q35869371 | ||
| Does Branched-Chain Amino Acids Supplementation Modulate Skeletal Muscle Remodeling through Inflammation Modulation? Possible Mechanisms of Action | Q35875721 | ||
| Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans | Q35941595 | ||
| Molecular mechanisms of glutamine action | Q36082609 | ||
| Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods. | Q36132887 | ||
| Rational role of amino acids in intestinal epithelial cells (Review). | Q36191993 | ||
| Muscle glutamine depletion in the intensive care unit. | Q36220847 | ||
| Stressing out over survival: glutamine as an apoptotic modulator. | Q36254208 | ||
| Branched-chain amino acid-enriched nutritional support in surgical and cancer patients | Q36347169 | ||
| Pathways from glutamine to apoptosis. | Q36486735 | ||
| Glutamine, gene expression, and cell function | Q36664320 | ||
| Glutamine metabolism and signaling in the liver | Q36664326 | ||
| Molecular mechanisms contributing to glutamine-mediated intestinal cell survival | Q36728699 | ||
| Nutritionally essential amino acids and metabolic signaling in aging | Q36746472 | ||
| Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver | Q36763107 | ||
| Leucine supplementation chronically improves muscle protein synthesis in older adults consuming the RDA for protein. | Q36806892 | ||
| Immune and cell modulation by amino acids | Q36864373 | ||
| Protein and amino acid metabolism in the human newborn. | Q37130495 | ||
| Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. | Q37149015 | ||
| Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis | Q37150025 | ||
| Schlafen 3, a novel gene, regulates colonic mucosal growth during aging | Q37162488 | ||
| Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells | Q37171062 | ||
| Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women | Q37198039 | ||
| Nonnutritive effects of glutamine | Q37275083 | ||
| Glutamine: a key substrate for the splanchnic bed. | Q37300725 | ||
| Glutamine, arginine, and leucine signaling in the intestine | Q37364534 | ||
| Control of mammalian gene expression by amino acids, especially glutamine | Q37403750 | ||
| Regulation of the aging process by autophagy | Q37452201 | ||
| Health effects of protein intake in healthy elderly populations: a systematic literature review | Q37588462 | ||
| Senescence and life span | Q37599560 | ||
| Effect of physical activity on glutamine metabolism | Q37617929 | ||
| Amino acid regulation of mammalian gene expression in the intestine | Q37699672 | ||
| Is glutamine a conditionally essential amino acid? | Q37783687 | ||
| Regulation of protein metabolism by glutamine: implications for nutrition and health | Q37825165 | ||
| mTOR signaling in disease | Q37941273 | ||
| Glutamine metabolism and its physiologic importance | Q37953214 | ||
| Amino acids and proteins in relation to the nutrition of elderly people | Q37972030 | ||
| Protein metabolism and requirements | Q38052972 | ||
| Dietary requirements of "nutritionally non-essential amino acids" by animals and humans | Q38068133 | ||
| Mechanisms regulating skeletal muscle growth and atrophy | Q38091731 | ||
| Nutritional strategies to attenuate muscle disuse atrophy | Q38095522 | ||
| Nutritional strategies to counteract muscle atrophy caused by disuse and to improve recovery | Q38127714 | ||
| Nutrition and protein energy homeostasis in elderly | Q38184244 | ||
| Current understanding of sarcopenia: possible candidates modulating muscle mass. | Q38209436 | ||
| Regulation of autophagy by amino acids and MTOR-dependent signal transduction | Q38216365 | ||
| Antiaging therapy: a novel target for antilipolytic drugs | Q38222661 | ||
| Glutamine and intestinal barrier function | Q38223273 | ||
| Citrulline and nitrogen homeostasis: an overview | Q38353698 | ||
| Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial | Q38468442 | ||
| Physiologic importance of glutamine | Q38674501 | ||
| Regulation of protein turnover by L-glutamine in porcine intestinal epithelial cells | Q39457914 | ||
| Stimulation by glutamine and proline of HGF production in hepatic stellate cells | Q40070532 | ||
| Glutamine regulates the human epithelial intestinal HCT-8 cell proteome under apoptotic conditions | Q40124526 | ||
| What is sarcopenia? | Q40378366 | ||
| Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells | Q40487451 | ||
| Effects of glutamine deprivation on protein synthesis in a model of human enterocytes in culture | Q40769125 | ||
| Hepatic glutaminase expression: relationship to kidney-type glutaminase and to the urea cycle. | Q40791470 | ||
| Cellular and molecular mechanisms of aging | Q40868697 | ||
| Regulation of glutaminase activity and glutamine metabolism | Q40926056 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 225-236 | |
| P577 | publication date | 2016-03-02 | |
| P1433 | published in | Nutrition Reviews | Q15765213 |
| P1476 | title | Glutamine metabolism in advanced age. | |
| P478 | volume | 74 |
| Q98568686 | Age-induced accumulation of methylmalonic acid promotes tumour progression |
| Q92191147 | Impact of a High Protein Intake on the Plasma Metabolome in Elderly Males: 10 Week Randomized Dietary Intervention |
| Q42362124 | Increased plasma proline concentrations are associated with sarcopenia in the elderly |
| Q91747192 | Metabolic Perturbations from Step Reduction in Older Persons at Risk for Sarcopenia: Plasma Biomarkers of Abrupt Changes in Physical Activity |
| Q38789489 | Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study |
| Q52314329 | Physical decline and survival in the elderly are affected by the genetic variability of amino acid transporter genes. |
| Q92536078 | Where Metabolism Meets Senescence: Focus on Endothelial Cells |
Search more.